Summary
TASER International, Inc. (now Axon Enterprise, Inc.) reported a significant improvement in financial performance for the first quarter of 2012 compared to the same period in 2011. Net sales increased by 10.9% to $25.6 million, primarily driven by strong adoption of the TASER X2 and increased sales of the X26 ECDs, including a significant order from the U.S. Army. The company also saw improved gross margins, rising to 59.4% from 52.8%, attributed to manufacturing efficiencies and a favorable product mix in the ECD segment. This operational improvement, combined with reduced litigation judgment expenses due to a favorable court ruling in the Turner case, led to a substantial increase in net income to $3.8 million ($0.07 per share) from a nominal $0.02 million ($0.00 per share) in the prior year. Cash flow from operations remained robust, providing $3.7 million, supporting a healthy cash balance of $29.7 million in cash, cash equivalents, and investments. The company also announced a new $20.0 million share repurchase program, signaling confidence in its financial position and future prospects. Despite ongoing litigation, the company appears to be navigating these challenges effectively, with a strong operational turnaround and positive financial outlook for the near term.
Financial Highlights
47 data points| Revenue | $25.64M |
| Cost of Revenue | $10.40M |
| Gross Profit | $15.24M |
| R&D Expenses | $2.13M |
| SG&A Expenses | $8.85M |
| Operating Income | $6.46M |
| Net Income | $3.80M |
| EPS (Basic) | $0.07 |
| EPS (Diluted) | $0.07 |
| Shares Outstanding (Basic) | 55.70M |
| Shares Outstanding (Diluted) | 56.36M |
Key Highlights
- 1Net sales increased by 10.9% to $25.6 million in Q1 2012 compared to Q1 2011, driven by strong ECD segment performance, particularly the TASER X2.
- 2Gross margin improved significantly to 59.4% from 52.8% in the prior year's quarter, indicating enhanced manufacturing efficiencies and a favorable product mix.
- 3Net income surged to $3.8 million ($0.07/share) from $0.02 million ($0.00/share) in Q1 2011, boosted by increased sales, improved margins, and a $2.2 million benefit from a litigation judgment reversal.
- 4Cash provided by operating activities was $3.7 million, contributing to a healthy cash, cash equivalents, and investments balance of $29.7 million as of March 31, 2012.
- 5A new $20.0 million share repurchase program was authorized by the Board of Directors, reflecting management's confidence in the company's financial health.
- 6The company continues to expand its product offerings, with traction seen in the AXON Flex on-officer camera and EVIDENCE.COM management service.
- 7Despite ongoing litigation, the company reported compliance with its debt covenants and has a strong liquidity position with no outstanding debt.